{"id":"W4399882468","doi":"10.1002/cncr.35438","title":"Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial","year":2024,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"EMD Serono; Genentech; National Cancer Institute; Sirtex Medical; Astellas Pharma; Invitae; Seagen; Bayer Vital; Advanced Accelerator Applications; Endocyte; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Medical Research Council; Celgene; Bayer; Prostate Cancer Foundation; Eli Lilly and Company; AstraZeneca; Lantheus Medical Imaging; Boston Scientific Corporation","keywords":"Medicine; Prostate cancer; Correlation; Quality of life (healthcare); Internal medicine; Prostate; Post-hoc analysis; Population; Oncology; Progression-free survival; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01332002,0.0006142342,0.001228302,0.0004449321,0.0002173692,0.0007625816,0.0006604515,0.0004523954,0.001291222],"category_scores_gemma":[0.01138887,0.0002760816,0.002197104,0.0007942197,0.0005294378,0.0004697165,0.0006094234,0.0009851538,0.0001548494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004823812,"about_ca_system_score_gemma":0.0008935346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009159506,"about_ca_topic_score_gemma":0.001193938,"domain_scores_codex":[0.9930422,0.005672136,0.0002032249,0.0005319578,0.0003927775,0.0001575909],"domain_scores_gemma":[0.991269,0.004070734,0.003006953,0.0007690539,0.0003361831,0.0005481335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2821082,0.002216885,0.6403081,0.0006759902,0.02191217,0.00007875442,0.0001587263,0.005899795,0.00170174,0.0003520914,0.002403775,0.0421837],"study_design_scores_gemma":[0.02948613,0.03762826,0.9092732,0.00007685341,0.008115689,0.0002165755,0.00008713525,0.01207978,0.0007998212,0.0006247876,0.001542318,0.00006937885],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99635,0.001862401,0.0004988106,0.00008983981,0.0000189133,0.0001319768,0.0006541008,0.00001970209,0.0003741226],"genre_scores_gemma":[0.9978079,0.0002013187,0.0004785701,0.00005838139,0.00002420292,0.000160467,0.00112703,0.000008233342,0.0001339141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01332002,"threshold_uncertainty_score":0.07044381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1994552131271834,"score_gpt":0.5489076594610065,"score_spread":0.3494524463338231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}